| 2021-05-05 | +86.0% | earnings | Seeking Alpha | Nemaura Medical rallies on 200K sugarBEAT sensors order |
| 2021-05-05 | +86.0% | legal | SEC EDGAR | NMRD 8-K: 8.01 and (SEC Filing) |
| 2023-01-27 | -43.7% | legal | Seeking Alpha | Nemaura Medical stock dips after pricing ~$8.4M securities offering |
| 2023-01-24 | +26.4% | news | Seeking Alpha | Nemaura says all patients in Miboko health program achieved weight loss |
| 2021-05-06 | -24.1% | earnings | Seeking Alpha | Nemaura Medical rallies on listing of sugarBEAT for reimbursement in Germany |
| 2024-09-26 | -19.3% | legal | SEC EDGAR | NMRD 8-K: 5.02, 7.01 (SEC Filing) |
| 2022-07-01 | -15.6% | legal | SEC EDGAR | NMRD 8-K: 2.02 and (SEC Filing) |
| 2023-12-13 | -13.5% | news | Seeking Alpha | Nemaura Medical receives positive Nasdaq listing decision |
| 2021-07-02 | -12.1% | news | Seeking Alpha | Nemaura: Wearable Monitoring Patches For Type-2 Diabetics Could Be An Inspired Move |
| 2022-11-14 | -12.1% | legal | SEC EDGAR | NMRD 8-K: 2.02 and (SEC Filing) |
| 2021-11-15 | -11.7% | earnings | Seeking Alpha | Nemaura Medical EPS misses by $0.04 |
| 2021-11-15 | -11.7% | legal | SEC EDGAR | NMRD 8-K: 2.02 and (SEC Filing) |
| 2022-08-15 | -9.9% | earnings | Seeking Alpha | Nemaura Medical GAAP EPS of -$0.17 |
| 2022-11-15 | -8.6% | earnings | Seeking Alpha | Nemaura Medical GAAP EPS of -$0.17 in-line, revenue of $0.07M misses by $0.06M |
| 2021-09-20 | -8.6% | news | Seeking Alpha | Nemaura Medical: From Believer To Skeptic |
| 2022-05-23 | +7.9% | legal | Seeking Alpha | Nemaura Medical secures $5M in non-dilutive funding |
| 2022-03-29 | +7.7% | analyst | Seeking Alpha | Nemaura Medical attracts Bull rating from HC Wainwright on glucose monitoring tech |
| 2023-01-31 | -7.6% | legal | SEC EDGAR | NMRD 8-K: 1.01, 3.02, 8.01 (SEC Filing) |
| 2021-06-30 | -7.6% | earnings | Seeking Alpha | Nemaura Medical EPS beats by $0.02 |
| 2021-06-30 | -7.6% | legal | SEC EDGAR | NMRD 8-K: 2.02, 7.01 (SEC Filing) |
| 2023-09-14 | -7.2% | news | Seeking Alpha | Nemaura Medical says compliance regain with Nasdaq rules not expected |
| 2021-08-16 | -6.7% | earnings | Seeking Alpha | Nemaura Medical EPS misses by $0.06 |
| 2021-08-16 | -6.7% | legal | SEC EDGAR | NMRD 8-K: 2.02, 7.01 (SEC Filing) |
| 2022-07-08 | -6.6% | legal | SEC EDGAR | NMRD 8-K: 5.02 (SEC Filing) |
| 2023-07-14 | -6.4% | legal | SEC EDGAR | NMRD 8-K: 2.02 and (SEC Filing) |
| 2023-10-12 | +6.4% | legal | SEC EDGAR | NMRD 8-K: 8.01 and (SEC Filing) |
| 2022-10-26 | +6.2% | legal | SEC EDGAR | NMRD 8-K: 1.01, 2.03 (SEC Filing) |
| 2023-08-14 | +5.7% | earnings | Seeking Alpha | Nemaura Medical GAAP EPS of -$0.09 beats by $0.06 |
| 2023-08-14 | +5.7% | legal | SEC EDGAR | NMRD 8-K: 2.02 and (SEC Filing) |
| 2021-09-17 | -5.2% | legal | SEC EDGAR | NMRD 8-K: 8.01 and (SEC Filing) |
| 2021-09-28 | -4.6% | legal | SEC EDGAR | NMRD 8-K: 7.01, 8.01 (SEC Filing) |
| 2022-06-18 | -4.4% | news | Value Research | Nemaura Medical Inc. (NMRD) Share Price Today | Nemaura Medical (NMRD) Live NSE/BSE - Value Research |
| 2021-09-30 | +4.0% | legal | SEC EDGAR | NMRD 8-K: 1.01 and (SEC Filing) |
| 2024-04-10 | +3.8% | legal | SEC EDGAR | NMRD 8-K: 1.01, 3.02, 5.02 (SEC Filing) |
| 2022-01-10 | -3.4% | legal | SEC EDGAR | NMRD 8-K: 5.02, 7.01 (SEC Filing) |
| 2022-09-16 | -2.7% | news | Seeking Alpha | Nemaura Medical (NMRD) Investor Presentation - Slideshow |
| 2022-03-10 | +2.7% | news | Seeking Alpha | Nemaura Medical: Opportunity In The Consumer-Centered Continuous Glucose Monitoring Market |
| 2022-06-30 | -2.1% | earnings | Seeking Alpha | Nemaura Medical GAAP EPS of -$0.59 misses by $0.12, revenue of $0.51M |
| 2021-07-26 | -1.5% | legal | SEC EDGAR | NMRD 8-K: 1.01 and (SEC Filing) |
| 2023-11-21 | +1.4% | legal | Seeking Alpha | Nemaura Medical secures $10M non-dilutive credit facility |
| 2023-11-21 | +1.4% | legal | SEC EDGAR | NMRD 8-K: 1.01, 2.03, 7.01 (SEC Filing) |
| 2022-04-01 | -1.4% | legal | SEC EDGAR | NMRD 8-K: 1.01 and (SEC Filing) |
| 2022-08-20 | +1.3% | news | Seeking Alpha | Nemaura Medical (NMRD) Investor Presentation - Slideshow |
| 2023-03-09 | +1.1% | news | Seeking Alpha | Nemaura Medical regains Nasdaq listing compliance |
| 2023-02-24 | -0.9% | earnings | Seeking Alpha | Nemaura Medical GAAP EPS of -$0.07, revenue of $0.03M |
| 2022-02-14 | -0.8% | earnings | Seeking Alpha | Nemaura Medical GAAP EPS of -$0.15, revenue of $0.18M |
| 2022-02-14 | -0.8% | news | GlobeNewswire | Nemaura Medical Announces Fiscal Third Quarter 2022 Financial Results and Provides Business Update - GlobeNewswire |
| 2021-09-27 | -0.7% | news | Seeking Alpha | Nemaura Medical in pact with MySugarWatch for glucose monitors |
| 2023-11-13 | +0.6% | earnings | Seeking Alpha | Nemaura Medical reports Q2 results |
| 2023-11-13 | +0.6% | legal | SEC EDGAR | NMRD 8-K: 2.02 and (SEC Filing) |
| 2021-07-23 | +0.3% | legal | SEC EDGAR | NMRD 8-K: 1.01 and (SEC Filing) |
| 2021-04-28 | — | legal | SEC EDGAR | NMRD 8-K: 2.02 and 7.01 (SEC Filing) |